Protagenic Therapeutics Inc. (PTIX) - Uzoq muddatli majburiyatlarning kapitalga nisbati
Protagenic Therapeutics (PTIX) neyroterapiya muolajalarini, xususan, xavotirga qarshi va antidepressant dori vositalarini tijoratlashtirish orqali daromad keltiradi, bu esa 0.00 indikatori bilan ko'rsatilgan narxlar grafigida aks etgan. ESG strategiyasining bir qismi sifatida, kompaniya o'z laboratoriyalarida energiya iste'molini va havoni tozalash tizimini optimallashtirmoqda. Shu bilan birga, jipslashgan boshqaruv jamoasi ehtiyotkor kapital boshqaruvi va klinik sinovlar uchun moslashuvchan rejalashtirishga rioya qilgan holda barqaror o'sish trayektoriyasini ta'minlaydi.
&width=1200&height=400&colorIndex=0&v=mvujvhid.si-7ayy9s0&start=20220704&end=20261030&filename=GURU_Markets_-_PTIX_-_Protagenic-Therapeutics_-_Long-Term-Debt-to-Equity-Ratio "PTIX - Protagenic Uzoq muddatli qarzning kapitalga nisbati 04.07.2022 - 10.01.2026 oraligʻida | 👁️GURU.Markets👁️")
Protagenic Therapeutics kompaniyasining tahliliy kesimlari
- joriy narx va aksiyalarning prognoz qilingan qiymati:
- bozor kapitallashuvi ko'rsatkichlari:
- xususiy kapitalning balans qiymati ko'rsatkichlari:
- qarz majburiyatlari va likvidlik statistikasi:
Qarzning kapitalga nisbati Protagenic Therapeutics|PTIX - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli majburiyatlarning o'z kapitaliga nisbati Protagenic|PTIX - Kompaniya qarzlari|Qarzning sof aktivlarga nisbati Protagenic Therapeutics, Inc.|PTIX - Kompaniyaning uzoq muddatli qarzi|Qisqa muddatli qarz Protagenic Therapeutics|Oraliq likvidlik koeffitsiyenti protagenic.com
- sof foyda va baholash koeffitsiyentlari ma'lumotlari:
Kompaniyaning har tomonlama tahlili:protagenic.com - PTIX
Protagenic Therapeutics depressiyaga qarshi kurashish uchun neyrobiologiya sohasidagi yuqori texnologik ishlanmalarga e'tibor qaratadi. Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichini tahlil qilish orqali biz bir yildan ortiq muddatga ega bo'lgan kreditlarning kapitalga nisbatan ulushini baholaymiz. Ushbu metrikaning past darajasi kompaniyaga nisbatan moliyaviy bosim minimal ekanligini anglatadi. Balansning bunday tuzilishi uzoq davom etadigan klinik sinovlar davomida brendning barqarorligini tasdiqlaydi. Konservativ leveraj bozor tebranishlari sharoitida ishonchli investitsiya himoyasini ta'minlaydi.
Raqobatdosh kompaniyalar tahlili
Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi BIIB (Biogen Inc)|Uzoq muddatli qarzning kapitalga nisbati NBIX|RGC - Uzoq muddatli majburiyatlarning kapitalga nisbati|Axsome Therapeutics - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati acadia-pharm.com ACAD|XENE - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti VKTX (Viking Therapeutics Inc)|Supernus Pharma (SUPN) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Catalyst Corp (CPRX)|Uzoq muddatli qarzning o'z kapitaliga nisbati Denali Therapeutics|harmonybiosciences.com - Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Biohaven (BHVN)|AMLX (Amylyx Pharmaceuticals Inc) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati Trevi Pharma TRVI|Praxis Corp (PRAX) - Uzoq muddatli majburiyatlarning kapitalga nisbati|AVXL: Uzoq muddatli qarzning o'z kapitaliga nisbati|ceribell.com - Uzoq muddatli kreditlarning kapitalga nisbati|PRTA: Uzoq muddatli qarzning kapitalga nisbati|Alector (ALEC) - Uzoq muddatli qarzning kapitalga nisbati|ANNX (Annexon Inc.) - Uzoq muddatli qarzning kapitalga nisbati|OMER - Uzoq muddatli qarzdorlikning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati NGNE|ACIU - Uzoq muddatli majburiyatlarning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Voyager Therapeutics, Inc. VYGR|NMRA: Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Scilex Holding Co. - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati Tevogen Bio Inc. TVGN|ACOG: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati cogrx.com|Uzoq muddatli qarzning o'z kapitaliga nisbati IKT|SAVA: Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati ASRT (Assertio Holdings, Inc.)|Uzoq muddatli kreditlarning kapitalga nisbati COYA|Uzoq muddatli qarzning kapitalga nisbati VTGN (Vistagen)|Uzoq muddatli qarzning kapitalga koeffitsiyenti OVID|Acumen Pharmaceuticals, Inc. - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati CervoMed, Inc.|alteritytherapeutics.com (ATHE) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Clene - Uzoq muddatli qarzning kapitalga koeffitsiyenti|PEPG (PepGen Inc) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati jupiterneurosciences.com|Uzoq muddatli qarzning o'z kapitaliga nisbati Relmada Therapeutics, Inc. (RLMD)|ANVS: Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati GRCE (Grace Therapeutics)|Firefly Neuro (AIFF) - Uzoq muddatli majburiyatlarning kapitalga nisbati|KLTO: Uzoq muddatli qarzning o'z kapitaliga nisbati|NRSN - Uzoq muddatli qarzning kapitalga nisbati|RVPH (Reviva Pharmaceuticals Holdings, Inc.) - Uzoq muddatli qarzning o'z kapitaliga nisbati|MTVA: Uzoq muddatli kreditlarning kapitalga nisbati|NRXS (NeurAxis, Inc) - Uzoq muddatli qarzning kapitalga nisbati|Helius Medical Technologies Inc. (HSDT) - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati PASG|Uzoq muddatli qarzning o'z kapitaliga nisbati bionomics.com.au NEUP|Uzoq muddatli qarzning o'z kapitaliga nisbati Minerva Neurosciences, Inc. NERV|Uzoq muddatli qarzdorlikning kapitalga nisbati Athira Pharma Inc (ATHA)|ADXN - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati ALZN|CYCN (cyclerion.com) - Uzoq muddatli qarzning o'z kapitaliga nisbati|KTTA: Uzoq muddatli kreditlarning kapitalga nisbati|CRGT (Cortigent Inc) - Uzoq muddatli qarzning kapitalga nisbati|Avenue Therapeutics Inc. (ATXI) - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati BCLI (Brainstorm Cell Therapeutics, Inc.)|Cara Therapeutics Inc - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Uzoq muddatli qarzning o'z kapitaliga nisbati Chromocell Therapeutics CHRO|ELYM: Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Intra-Cellular - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Longboard Pharmaceuticals Inc|MRNS (Marinus) - Uzoq muddatli qarzning o'z kapitaliga nisbati|NKGen Biotech Corp (NKGN) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati NeuroBo Pharmaceuticals|SAGE: Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati Synaptogenix (SNPX)|TRVN - Uzoq muddatli majburiyatlarning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Vigil Neuroscience, Inc. VIGL|WENA (Anew Medical Inc.) - Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|CERE - Uzoq muddatli qarzning o'z kapitaliga nisbati